- Previous Close
204.80 - Open
208.20 - Bid 208.20 x --
- Ask 208.20 x --
- Day's Range
204.60 - 208.20 - 52 Week Range
156.00 - 268.00 - Volume
60,341 - Avg. Volume
79,002 - Market Cap (intraday)
28.2B - Beta (5Y Monthly) 1.80
- PE Ratio (TTM)
-- - EPS (TTM)
-28.10 - Earnings Date Jan 30, 2025
- Forward Dividend & Yield 1.00 (0.49%)
- Ex-Dividend Date Apr 26, 2024
- 1y Target Est
272.00
Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
www.vitrolife.comRecent News: VITR.ST
View MorePerformance Overview: VITR.ST
Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VITR.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VITR.ST
View MoreValuation Measures
Market Cap
27.74B
Enterprise Value
28.86B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.80
Price/Book (mrq)
2.11
Enterprise Value/Revenue
8.12
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-107.03%
Return on Assets (ttm)
2.54%
Return on Equity (ttm)
-24.89%
Revenue (ttm)
3.56B
Net Income Avi to Common (ttm)
-3.8B
Diluted EPS (ttm)
-28.10
Balance Sheet and Cash Flow
Total Cash (mrq)
925M
Total Debt/Equity (mrq)
15.60%
Levered Free Cash Flow (ttm)
723.37M